10.1002/chem.201703774
Chemistry - A European Journal
FULL PAPER
sodium methoxide and bromine, bromodesilylation occurred in
95% yield to form vinyl bromide 7. Subsequent Sonogashira
cross coupling conditions using Pd(dppf)Cl2 and 4-
Acknowledgements
We acknowledge financial support by the National Science
Foundation (CHE-1414458).
ethynylanisole at room temperature afforded
a
densely
substituted alkene 8 bearing a highly conjugated enyne moiety;
this is a product that is previously inaccessible. In addition, 3a
underwent rapid oxidation and desilylation within minutes to
generate β-ketoamide 9. β-ketoamides are key intermediates in
the synthesis of dipeptidyl peptidase IV inhibitor, Sitaligpin
(Januvia), which is an FDA approved drug for the treatment of
Type 2 diabetes mellitus.[14]
Keywords: chemoselectivity • diastereoselectivity • synthetic
methods • boron • silicon
[1]
a) A. Barbero, F. J. Pulido, Acc. Chem. Res. 2004, 37, 817-825; b) I.
Fleming, R. Henning, D. C. Parker, H. E. Plaut, P. E. J. Sanderson, J.
Chem. Soc. Perkin Trans. 1 1995, 317-337; c) K. Tamao, N. Ishida, T.
Tanaka, M. Kumada, Organometallics 1983, 2, 1694-1696; d) A. J. J.
Lennox, G. C. Lloyd-Jones, Chem. Soc. Rev. 2014, 43, 412-443; e) N.
Miyaura, A. Suzuki, Chem. Rev. 1995, 95, 2457-2483; f) S. E. Denmark,
J. H. C. Liu, Angew. Chem. Int. Ed. 2010, 49, 2978-2986; Angew.
Chem. 2010, 122, 3040-3049; g) Y. Nakao, T. Hiyama, Chem. Soc.
Rev. 2011, 40, 4893-4901.
Conclusions
In conclusion, we have developed a novel Brønsted base-
mediated silaboration method that exclusively affords (Z)-α-silyl-
β-boryl acrylamides in a manner that is both mild and transition
metal-free. The installation of the boryl and silyl group in a trans
fashion is achieved through Lewis acid-base adduct formation
[2]
[3]
J. Jiao, K. Nakajima, Y. Nishihara, Org. Lett. 2013, 15, 3294-3297.
a) A. Adamczyk-Woźniak, O. Komarovska-Porokhnyavets, B.
Misterkiewicz, V. P. Novikov, A. Sporzyński, Appl. Organomet. Chem.
2012, 26, 390-393; b) B. A. Teicher, G. Ara, R. Herbst, V. J. Palombella,
J. Adams, Clin. Cancer Res. 1999, 5, 2638-2645; c) E. Sonoiki, C. L.
Ng, M. C. S. Lee, D. Guo, Y.-K. Zhang, Y. Zhou, M. R. K. Alley, V.
Ahyong, L. M. Sanz, M. J. Lafuente-Monasterio, C. Dong, P. G. Schupp,
J. Gut, J. Legac, R. A. Cooper, F.-J. Gamo, J. DeRisi, Y. R. Freund, D.
A. Fidock, P. J. Rosenthal, Nat. Commun. 2017, 8, 14574.
with Suginome’s reagent and sequential intramolecular
α
silylation-β borylation. A wide variety of N- and aryl substitutions
are tolerated with products being indefinitely stable to air at
ambient conditions. The utility of 1,2-vinylborasilanes is
demonstrated by chemoselective cross-coupling reactions and
subsequent chemical transformations.
[4]
[5]
M. Oestreich, E. Hartmann, M. Mewald, Chem. Rev. 2013, 113, 402-
441.
a) M. Suginome, T. Matsuda, H. Nakamura, Y. Ito, Tetrahedron 1999,
55, 8787-8800; b) M. B. Ansell, J. Spencer, O. Navarro, ACS Catal.
2016, 6, 2192-2196; c) T. Ohmura, K. Oshima, H. Taniguchi, M.
Suginome, J. Am. Chem. Soc. 2010, 132, 12194-12196; d) M.
Suginome, H. Nakamura, Y. Ito, Chem. Commun. 1996, 2777-2778; e)
H. N. M. Suginome, T. Hasui, M. Murakami, Bull. Chem. Soc. Jpn. 2005,
78, 323-326; f) J. Carlos Araujo Da Silva, M. Birot, J.-P. Pillot, M.
Pétraud, J. Organomet. Chem. 2002, 646, 179-190; g) S.-y. Onozawa,
Y. Hatanaka, M. Tanaka, Chem. Commun. 1997, 1229-1230; h) T.
Ohmura, K. Oshima, M. Suginome, Chem. Commun. 2008, 1416-1418.
C. Gryparis, M. Stratakis, Org. Lett. 2014, 16, 1430-1433.
Experimental
General procedure
Under nitrogen atmosphere, a solution of propargylamide (1
equiv.) and 12-crown-4 (1.4 equiv.) in THF at -78 °C was added
phenyllithium (1.4 equiv.) dropwise and stirred at -78 °C for 15
min. The borosilane (pinBSiMe2Ph, 1.4 equiv) was then added
dropwise and the solution was allowed to warm to rt, then
heated to 60 °C for 30 min. The reaction mixture was
concentrated in vacuo and subsequently purified by column
chromatography using a 10-40% gradient of ethyl acetate in
DCM to yield the desired product.
[6]
[7]
[8]
[9]
K. Nagao, H. Ohmiya, M. Sawamura, Org. Lett. 2015, 17, 1304-1307.
M. Suginome, T. Matsuda, Y. Ito, Organometallics 2000, 19, 4647-4649.
a) M. Suginome, H. Nakamura, Y. Ito, Angew. Chem. Int. Ed. 1997, 36,
2516-2518; Angew. Chem. 1997, 109, 2626-2628; b) M. Gerdin, M.
Penhoat, R. Zalubovskis, C. Pétermann, C. Moberg, J. Organomet.
Chem. 2008, 693, 3519-3526; c) M. Suginome, T. Matsuda, T.
Yoshimoto, Y. Ito, Org. Lett. 1999, 1, 1567-1569; d) M. Suginome, T.
Matsuda, T. Yoshimoto, Y. Ito, Organometallics 2002, 21, 1537-1539.
(Z)-2-(dimethyl(phenyl)silyl)-N-methyl-3-phenyl-3-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)acrylamide
(3a):
[10] a) H. Ito, Y. Horita, E. Yamamoto, Chem. Commun. 2012, 48, 8006-
8008; b) T. Kurahashi, T. Hata, H. Masai, H. Kitagawa, M. Shimizu, T.
Hiyama, Tetrahedron 2002, 58, 6381-6395.
propargylamide (50 mg, 0.31 mmol); phenyllithium (230 µL, 0.44
mmol); pinBSiMe2Ph (120 µL, 0.44 mmol); 12-crown-4 (71 µL,
0.44 mmol). White solid; 1H NMR (400 MHz, CDCl3) δ 7.56-7.51
(m, 2H), 7.46-7.39 (m, 3H), 7.34-7.28 (m, 2H), 7.25-7.20 (m, 3H),
5.60 (brs, 1H), 2.70 (d, J = 5.2, 3H), 1.05 (s, 12H), 0.11 (s, 6H).
13C NMR (100 MHz, CDCl3) δ 177.9, 141.8, 137.5, 134.3, 130.6,
129.6, 129.0, 127.4, 126.6, 125.7, 80.3, 28.7, 25.4, -1.27. 11B
NMR (128 MHz, CDCl3) δ 13.0. HRMS: (ESI) [M+H]+ calc for
C24H33BNO3Si, 422.2323, observed, 422.2313.
[11] M. Shimizu, T. Kurahashi, H. Kitagawa, T. Hiyama, Org. Lett. 2003, 5,
225-227.
[12] H. Li, X. H. Shangguan, Z. K. Zhang, S. Huang, Y. Zhang, J. B. Wang,
Org. Lett. 2014, 16, 448-451.
[13] A. Verma, R. F. Snead, Y. Dai, C. Slebodnick, Y. Yang, H. Yu, F. Yao,
W. L. Santos, Angew. Chem. Int. Ed. 2017, 56, 5111; Angew. Chem.
2017, 129, 5193.
[14] K. B. Hansen, Y. Hsiao, F. Xu, N. Rivera, A. Clausen, M. Kubryk, S.
Krska, T. Rosner, B. Simmons, J. Balsells, N. Ikemoto, Y. Sun, F.
Spindler, C. Malan, E. J. J. Grabowski, J. D. Armstrong, J. Am. Chem.
Soc. 2009, 131, 8798-8804.
This article is protected by copyright. All rights reserved.